Nonalcoholic Steatohepatitis
📧 Sign up to get email alerts when something new happens for Nonalcoholic Steatohepatitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-06-04Clinical Trial Update: Combination Obeticholic Acid (OCA) and Statins for Monitoring of Lipids (CONTROL) [Phase 2]
A Phase 2 trial update (CONTROL) investigates the combination of obeticholic acid and statins for lipid monitoring in patients with nonalcoh…
-
CLINICAL_TRIALS trial_result · 2017-11-06Clinical Trial Update: Drug-drug Interaction Study Between EDP-305, Intraconazole and Rifampin in Healthy Volunteers [Phase 1]
A Phase 1 study evaluated potential drug-drug interactions between EDP-305 and the antifungals itraconazole and rifampin in healthy voluntee…
-
CLINICAL_TRIALS trial_result · 2017-11-06Clinical Trial Update: A Study of EDP-305 in Subjects With Mild and Moderate Hepatic Impairment Compared With Normal Healthy Volunteers [Phase 1]
Phase 1 study assessing EDP-305 in subjects with mild to moderate hepatic impairment versus healthy volunteers in the context of nonalcoholi…
-
CLINICAL_TRIALS trial_result · 2017-10-10Clinical Trial Update: Effect of Dietary and Life Style Modification on Post Liver Transplant Obesity [NA]
A trial evaluating dietary and lifestyle modifications to address obesity after liver transplantation was terminated.
-
CLINICAL_TRIALS trial_result · 2017-06-14Clinical Trial Update: Clinical Protocol to Investigate the Efficacy of Recombinant Human Leptin (Metreleptin) in Nonalcoholic Steatohepatitis (NASH) or Nonalcoholic Fatty Liver Disease (NAFLD) Associated With Lipodystrophy [Phase 2]
A Phase 2 clinical trial evaluating metreleptin for nonalcoholic fatty liver disease and nonalcoholic steatohepatitis associated with lipody…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-05-30Clinical Trial Update: The Role of Leptin Receptors in NASH
This clinical trial evaluated the role of leptin receptors in nonalcoholic steatohepatitis (NASH) and metabolic syndrome; the study has comp…
-
CLINICAL_TRIALS trial_result · 2017-05-24Clinical Trial Update: A Study of BMS-986171 in Healthy People to Assess Safety, to Measure Blood Levels of Drug, and to Find Out What the Drug Does to the Body [Phase 1]
Phase 1 study of BMS-986171 in healthy volunteers to assess safety, pharmacokinetics, and pharmacodynamics; the trial has completed.
-
CLINICAL_TRIALS trial_result · 2017-05-16Clinical Trial Update: Nutritional Counseling vs. Nutritional Supplements for NASH - a Randomized Prospective, Open Label Pilot Study [Phase 2]
Phase 2 randomized pilot comparing nutritional counseling to nutritional supplements for nonalcoholic fatty liver disease and nonalcoholic s…
-
CLINICAL_TRIALS trial_result · 2017-04-28Clinical Trial Update: Genetic Effect on Omega 3 Fatty Acids for the Treatment of Fatty Liver Disease [NA]
A completed Yale University clinical trial investigated the genetic influence on omega-3 fatty acids for treating nonalcoholic fatty liver d…
-
CLINICAL_TRIALS trial_result · 2017-04-26Clinical Trial Update: Testosterone Replacement in Non-alcoholic Steatohepatitis (TEREPINS) [Phase 2]
Phase 2 trial TERPINS evaluating testosterone replacement for nonalcoholic steatohepatitis in men with hypogonadism has completed.
-
CLINICAL_TRIALS trial_result · 2017-04-05Clinical Trial Update: University of Texas H.S.C. San Antonio Pioglitazone in Non-Alcoholic Steatohepatitis Trial (UTHSCSA NASH Trial) [Phase 4]
This entry reports the completion of a Phase 4 trial evaluating pioglitazone for nonalcoholic steatohepatitis (NASH) and related fatty liver…
-
CLINICAL_TRIALS trial_result · 2017-03-21Clinical Trial Update: Safety and Efficacy of Solithromycin in the Treatment of Nonalcoholic Steatohepatitis Without Cirrhosis [Phase 2]
Phase 2 clinical trial results assessing safety and efficacy of solithromycin in nonalcoholic steatohepatitis without cirrhosis; the study h…
-
CLINICAL_TRIALS trial_result · 2017-03-17Clinical Trial Update: Impact of Text Messaging in the Management of Non-alcoholic Fatty Liver Disease [NA]
A completed clinical trial evaluating whether a text messaging program can aid in the management of non-alcoholic fatty liver disease and no…
-
CLINICAL_TRIALS trial_result · 2017-03-14Clinical Trial Update: Sitagliptin for the Treatment of Non-alcoholic Steatohepatitis in Patients With Type 2 Diabetes [NA]
A clinical trial evaluating sitagliptin for non-alcoholic steatohepatitis in patients with type 2 diabetes has been terminated.
-
CLINICAL_TRIALS trial_result · 2017-02-08Clinical Trial Update: A Phase II Study of the Effect of a Low Calorie Diet on Patients Undergoing Liver Resection [NA]
A completed Phase II clinical trial evaluated the impact of a low-calorie diet on patients undergoing liver resection.
-
CLINICAL_TRIALS trial_result · 2016-12-09Clinical Trial Update: Recombinant Leptin Therapy for Treatment of Nonalcoholic Steatohepatitis (NASH) [Phase 2]
This update reports Phase 2 trial results for recombinant leptin therapy in nonalcoholic steatohepatitis (NASH).
-
CLINICAL_TRIALS trial_result · 2016-11-28Clinical Trial Update: Impact of Bariatric Surgery on Nonalcoholic Fatty Liver Disease
A completed clinical trial evaluated the impact of bariatric surgery on nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.
-
CLINICAL_TRIALS trial_result · 2016-07-21Clinical Trial Update: A Study of IDN-6556 in Subjects With NAFLD and Raised Transaminases [Phase 2]
Completed Phase 2 clinical trial of Emricasan (IDN-6556) in subjects with nonalcoholic fatty liver disease and nonalcoholic steatohepatitis;…
-
CLINICAL_TRIALS trial_result · 2016-05-18Clinical Trial Update: An Efficacy and Safety Study of Rimonabant for Treatment of Nonalcoholic Steatohepatitis (NASH) in Patients With Type 2 Diabetes [Phase 3]
Phase 3 trial evaluating rimonabant for nonalcoholic steatohepatitis in patients with type 2 diabetes was terminated; no final efficacy resu…
-
CLINICAL_TRIALS trial_result · 2016-05-18Clinical Trial Update: An Efficacy and Safety Study of Rimonabant for Treatment of Nonalcoholic Steatohepatitis (NASH) in Patients Without Diabetes [Phase 3]
Phase 3 trial of rimonabant for nonalcoholic steatohepatitis in non-diabetic patients has been terminated.
-
CLINICAL_TRIALS trial_result · 2016-05-12Clinical Trial Update: Role of Exenatide in NASH-a Pilot Study [Phase 2, Phase 3]
Clinical trial update showing a pilot Phase 2/3 study of exenatide in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Res…
-
CLINICAL_TRIALS trial_result · 2016-03-23Clinical Trial Update: Liraglutide Efficacy and Action in Non-Alcoholic Steatohepatitis [Phase 2]
A Phase 2 trial evaluating liraglutide for nonalcoholic steatohepatitis has completed, with updates on its efficacy and mechanism of action.
-
CLINICAL_TRIALS trial_result · 2016-03-22Clinical Trial Update: The Effects of Flaxseed Supplement on Biochemical Factors and Hepatic Fibrosis in Patients With Nonalcoholic Fatty Liver Disease [Phase 2, Phase 3]
A Phase 2/3 clinical trial evaluating the effects of a flaxseed supplement on biochemical factors and hepatic fibrosis in patients with nona…
-
CLINICAL_TRIALS trial_result · 2016-02-23Clinical Trial Update: Safety and Efficacy of Roflumilast and Pioglitazone in Treating Adults With Nonalcoholic SteatoHepatitis [Phase 2]
Phase 2 trial evaluating safety and efficacy of roflumilast and pioglitazone in adults with nonalcoholic steatohepatitis was terminated; res…
-
CLINICAL_TRIALS trial_result · 2016-01-14Clinical Trial Update: Efficacy and Tolerance of Treatment With DHA, Choline and Vitamin E in Children With Non-alcoholic Steatohepatitis [Phase 3]
Phase 3 trial in children with nonalcoholic steatohepatitis evaluating the efficacy and tolerability of DHA, choline, and vitamin E has comp…